Dr. Lal Path Labs Ltd. has informed the Exchange that the Board of Directors at its meeting held on October 31, 2025, have considered and approved bonus at the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held.
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Dr. Lal Path Labs, at its meeting held on October 31, 2025, approved a bonus issue of equity shares in the ratio of 1:1. This means every shareholder will receive 1 bonus equity share for every 1 equity share held in the company. The bonus shares will increase the total outstanding share count, effectively doubling the share base, though it does not change the company's overall market value. The record date and other timelines for determining eligible shareholders will typically be announced separately.
The share price is expected to adjust downward on the ex-date to reflect the doubled share count, while each shareholder's total holding value remains unchanged in the short term. Long-term impact depends on the company's continued earnings growth, as bonus issues are often seen as a sign of management confidence in future prospects.